TNF inhibitor prices rose despite increased drug class competitionFebruary 20, 2019Rheumatoid ArthritisBusiness of Medicine
TNFi use may not affect joint replacement rates for RA patientsFebruary 14, 2019Rheumatoid ArthritisOrthopedicsOrthopedics
ICYMI: MRI-based treat-to-target approach offers no benefit for RA patientsFebruary 5, 2019Rheumatoid Arthritis
Findings in seropositive arthralgia patients may help to predict RAJanuary 31, 2019Rheumatoid Arthritis
Experts cite different approaches to try for methotrexate-related nausea, fatigueJanuary 30, 2019Rheumatoid Arthritis
Stopping TNF inhibitors before 20 weeks’ gestation not linked to worsening RA, JIAJanuary 29, 2019Rheumatoid Arthritis
Women with RA have reduced chance of live birth after assisted reproduction treatmentJanuary 27, 2019Rheumatoid Arthritis
Treat-to-target approach for CVD risk factors decreased atherosclerosis in RA patientsJanuary 16, 2019Rheumatoid Arthritis
Blood test shows potential as an early biomarker of methotrexate inefficacyJanuary 11, 2019Rheumatoid Arthritis
Jakinib explosion for RA: Where do they fit in clinical practice?December 27, 2018Rheumatoid Arthritis
New insight gained into natural history of interstitial pneumonia with autoimmune featuresDecember 17, 2018Lupus & Connective Tissue DiseasesRheumatoid Arthritis
